Abstract
Circulating endothelial progenitor cells (EPCs) are bone marrow-derived stem cells able to migrate to sites of damaged endothelium and differentiate into endothelial cells, thereby contributing to vascular repair. Recent studies demonstrated a reduction of EPCs in patients with diabetes mellitus or erectile dysfunction (ED). The aim of this study was to evaluate the circulating levels of different EPCs phenotypes and their relation with testosterone levels in young type 1 diabetic patients with ED. We studied 118 consecutively type 1 diabetic patients and 60 age-matched healthy controls. Erectile function was assessed by completing the International Index of Erectile Function (IIEF-5) and EPCs levels by flow cytometry. Testosterone concentrations were evaluated in all the study population. We identified 38 diabetic patients with ED (Group 1) and 80 patients without ED (Group 2). CD34+KDR+CD133+ cells were significantly lower in patients in Group 1 as compared with those in Group 2 [median and interquartile range, n/106 events, 12 (6–16) vs. 18 (13–22), P < 0.001)]. In all participants in the study, there was a significant correlation between circulating CD34+KDR+CD133+ cells and testosterone levels (r = 0.410, P < 0.001), which was highest in Group 1, intermediate in Group 2, and lowest in Group 3 (controls). There was a significant correlation between IIEF-5 score and both CD34+KDR+ (r = 0.459, P = 0.003) and CD34+KDR+CD133+ (r = 0.316, P = 0.050) cells among patients of Group 1, as well as between testosterone levels and most of the EPCs phenotypes. Finally, multivariate regression analysis identified levels of circulating CD34+KDR+ cells as an independent risk factor for ED (β-coefficient 0.348, P = 0.007). In conclusion, type 1 diabetic patients with ED show reduced levels of CD34+KDR+CD133+ cells, whose number correlates with IIEF. Further studies are needed to fully understand the exact mechanisms by which testosterone regulates vascular homeostasis.
Similar content being viewed by others
References
D. Fedele, C. Coscelli, F. Santeusanio, A. Bortolotti, L. Chatenoud, E. Colli, M. Landoni, F. Parazzini, Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care 21, 1973–1977 (1998)
C.G. Bacon, F.B. Hu, E. Giovannucci, D.B. Glasser, M.A. Mittleman, E.B. Rimm, Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25, 1458–1463 (2002)
M. Buysschaert, J.L. Medina, M. Bergman, A. Shah, J. Lonier, Prediabetes and associated disorders. Endocrine (2014). doi:10.1007/s12020-014-0436-2
A. Sansone, F. Romanelli, D. Gianfrilli, A. Lenzi, Endocrine evaluation of erectile dysfunction. Endocrine 46, 423–430 (2014)
S.C. Siu, S.K. Lo, K.W. Wong, K.M. Ip, Y.S. Wong, Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med. 18, 732–738 (2001)
L.S. Malavige, S.D. Jayaratne, S.T. Kathriarachchi, S. Sivayogan, D.J. Fernando, J.C. Levy, Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J. Sex. Med. 5, 2125–2134 (2008)
F. Giugliano, M.I. Maiorino, G. Bellastella, M. Gicchino, D. Giugliano, K. Esposito, Determinants of erectile dysfunction in type 2 diabetes. Int. J. Impot. Res. 22, 204–209 (2010)
H. Sasaki, H. Yamasaki, K. Ogawa, K. Nanjo, R. Kawamori, Y. Iwamoto, S. Katayama, M. Shirai, Prevalence and risk factors for erectile dysfunction in Japanese diabetics. Diabetes Res. Clin. Pract. 70, 81–89 (2005)
V.S. Thorve, A.D. Kshirsagar, N.S. Vyawahare, V.S. Joshi, K.G. Ingale, R.J. Mohite, Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J. Diabetes Complicat. 25, 129–136 (2011)
J.Y. Dong, Y.H. Zhang, L.Q. Qin, Erectile dysfunction and risk of cardiovascular disease meta-analysis of prospective cohort studies. J. Am. Coll. Cardiol. 58, 1378–1385 (2011)
G. Gandaglia, A. Salonia, N. Passoni, P. Montorsi, A. Briganti, F. Montorsi, Erectile dysfunction as a cardiovascular risk factor in patients with diabetes. Endocrine 43, 285–292 (2013)
S.J. Turek, S.M. Hastings, J.K. Sun, G.L. King, H.A. Keenan, Sexual dysfunction as a marker of cardiovascular disease in males with 50 or more years of type 1 diabetes. Diabetes Care 36, 3222–3226 (2013)
K. Esposito, M. Ciotola, F. Giugliano, L. Sardelli, F. Giugliano, M.I. Maiorino, F. Beneduce, M. De Sio, D. Giugliano, Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction. J. Sex. Med. 5, 1436–1442 (2008)
D.R. Meldrum, J.C. Gambone, M.A. Morris, D.A. Meldrum, K. Esposito, L.J. Ignarro, The link between erectile and cardiovascular health: the canary in the coal mine. Am. J. Cardiol. 15, 599–606 (2011)
D. Burger, R.M. Touyz, Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J. Am. Soc. Hypertens. 6, 85–99 (2012)
C. Urbich, S. Dimmeler, Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 20, 343–353 (2004)
M. Zhang, A.B. Malik, J. Rehman, Endothelial progenitor cells and vascular repair. Curr. Opin. Hematol. 21, 224–228 (2014)
J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, A.A. Quyyumi, T. Finkel, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593–600 (2003)
G.P. Fadini, E. Boscaro, S. de Kreutzenberg, C. Agostini, F. Seeger, S. Dimmeler, A. Zeiher, A. Tiengo, A. Avogaro, Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 33, 1097–1102 (2010)
T. Hörtenhuber, B. Rami-Mehar, M. Satler, K. Nagl, C. Höbaus, F. Höllerl, R. Koppensteiner, G. Schernthaner, E. Schober, G.H. Schernthaner, Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 36, 1647–1653 (2013)
C. Foresta, N. Caretta, A. Lana, A. Cabrelle, G. Palu, A. Ferlin, Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int. J. Impot. Res. 17, 288–290 (2005)
S. Dimmeler, A.M. Zeiher, Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J. Mol. Med. 82, 671–677 (2004)
C. Foresta, D. Zuccarello, L. De Toni, A. Garolla, N. Caretta, A. Ferlin, Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin. Endocrinol. 68, 284–289 (2008)
J. Cai, Y. Hong, C. Weng, C. Tan, J. Imperato-McGinley, Y.S. Zhu, Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism. Am. J. Physiol. Heart Circ. Physiol. 300, H1210–H1221 (2011)
R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, B.M. Pena, Development and evaluation of an abridged, 5-item version of the International Index of erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int. J. Impot. Res. 11, 319–326 (1999)
M.I. Maiorino, E. Della Volpe, L. Olita, G. Bellastella, D. Giugliano, K. Esposito, Glucose variability inversely associates with endothelial progenitor cells in type 1 diabetes. Endocrine. doi:10.1007/s12020-014-0277-z (2014)
F.C. Wu, A. Tajar, J.M. Beynon, S.R. Pye, A.J. Silman, J.D. Finn, T.W. O’Neill, G. Bartfai, F.F. Casanueva, G. Forti, A. Giwercman, T.S. Han, K. Kula, M.E. Lean, N. Pendleton, M. Punab, Boonen Vanderschueren, D., Labrie, F., Huhtaniemi, I.T., EMAS Group.: Identification of late-onset hypogonadism in middleaged and elderly men. N. Engl. J. Med. 363, 123–135 (2010)
M. Murata, H. Tamemoto, T. Otani, S. Jinbo, N. Ikeda, M. Kawakami, S.E. Ishikawa, Endothelial impairment and bone marrow-derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction. J. Diabetes Investig. 20, 526–533 (2012)
S. La Vignera, R.A. Condorelli, S. Tumino, M. Di Mauro, E. Vicari, A.E. Calogero, Original evaluation of endothelial dysfunction in men with erectile dysfunction and metabolic syndrome. Int. J. Impot. Res. 24, 150–154 (2012)
S. La Vignera, R. Condorelli, E. Vicari, R. D’Agata, A. Calogero, Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy. Aging Male 14, 183–189 (2011)
R.A. Condorelli, A.E. Calogero, E. Vicari, L. di Pino, F. Giacone, L. Mongioì, S. la Vignera, Arterial erectile dysfunction and peripheral arterial disease: reliability of a new phenotype of endothelial progenitor cells and endothelial microparticles. J. Androl. 33, 1268–1675 (2012)
S. Sen, S.P. McDonald, P.T. Coates, C.S. Bonder, Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin. Sci. (Lond.) 120, 263–283 (2011)
K. Esposito, M. Ciotola, M.I. Maiorino, F. Giugliano, R. Autorino, M. De Sio, E. Jannini, A. Lenzi, D. Giugliano, Circulating CD34+KDR+ endothelial progenitor cells correlate with erectile function and endothelial function in overweight men. J. Sex. Med. 6, 107–114 (2009)
N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Böhm, G. Nickenig, Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 8, 999–1007 (2005)
C. Schmidt-Lucke, L. Rössig, S. Fichtlscherer, M. Vasa, M. Britten, U. Kämper, S. Dimmeler, A.M. Zeiher, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 7, 2981–2987 (2005)
G.P. Fadini, A. Coracina, I. Baesso, C. Agostini, A. Tiengo, A. Avogaro, S.V. de Kreutzenberg, Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37, 2277–2282 (2006)
K. Eisermann, C.J. Broderick, A. Bazarov, M.M. Moazam, G.C. Fraizer, Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site. Mol. Cancer. 12, 7 (2013)
R. Liu, L. Ding, M.H. Yu, H.Q. Wang, W.C. Li, Z. Cao, P. Zhang, B.C. Yao, J. Tang, Q. Ke, T.Z. Huang, Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells. Endocrine 46, 634–643 (2014)
E. García-Cruz, A. Leibar-Tamayo, J. Romero, M. Piqueras, P. Luque, O. Cardeñosa, A. Alcaraz, Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med. 10, 2529–2538 (2013)
C. Foresta, N. Caretta, A. Lana, L. De Toni, A. Biagioli, A. Ferlin, A. Garolla, Reduced number of circulating endothelial progenitor cells in hypogonadal men. J. Clin. Endocrinol. Metab. 91, 4599–4602 (2006)
G.P. Fadini, M. Albiero, A. Cignarella, C. Bolego, C. Pinna, E. Boscaro, E. Pagnin, R. De Toni, S. de Kreutzenberg, C. Agostini, A. Avogaro, Effects of androgens on endothelial progenitor cells in vitro and in vivo. Clin. Sci. (Lond). 7, 355–364 (2009)
Acknowledgments
The authors thank Dr. Filomena Castaldo and Dr. Laura Olita for technical support and collection of data.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maiorino, M.I., Bellastella, G., Petrizzo, M. et al. Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction. Endocrine 49, 415–421 (2015). https://doi.org/10.1007/s12020-014-0478-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0478-5